class name | count |
---|---|
rosids | 8 |
class name | count |
---|---|
Euphorbiaceae | 7 |
Thymelaeaceae | 1 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00003422
![]() |
Diterpenoid EF-D
|
CHEMBL520853
|
![]() |
|||
C00003464
![]() |
12-O-Palmitoyl-16-hydroxyphorbol 13-acetate
|
CHEMBL2012888
|
C028113
|
![]() |
||
C00003466
![]() |
Phorbol 12-tiglate 13-decanoate
|
C011986
|
![]() |
|||
C00003491
![]() |
12-Tetradecanoylphorbol 13-acetate
|
CHEMBL291793
CHEMBL279115 CHEMBL1328542 CHEMBL1441758 CHEMBL1443384 CHEMBL1446902 CHEMBL1515083 |
D013755
|
57 / 57 / 76 | 471 / 23 |
![]() |
C00040076
![]() |
Prostratin
|
CHEMBL170518
CHEMBL1980156 |
C070999
|
9 / 2 / 2 |
![]() |
|
C00044231
![]() |
Mellerin A
/ (+)-Mellerin A |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00003491 C00040076 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00003491 C00040076 | 1 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00003491 C00040076 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00003491 C00040076 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00003491 C00040076 | 1 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00003491 C00040076 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00003491 C00040076 | 0 / 1 |
Q05655 | Protein kinase C delta type | Delta | C00003491 C00040076 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00003491 C00040076 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003491 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00003491 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003491 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003491 | 11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003491 | 3 / 2 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003491 | 2 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003491 | 0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00003491 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00003491 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003491 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00003491 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003491 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00003491 | 1 / 1 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00003491 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00003491 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00003491 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00003491 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003491 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00003491 | 3 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00003491 | 2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00003491 | 5 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003491 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003491 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00003491 | 4 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003491 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003491 | 0 / 1 |
Q8IV61 | Ras guanyl-releasing protein 3 | Other cytosolic protein | C00003491 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00003491 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00003491 | 1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00003491 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00003491 | 4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00003491 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00003491 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00003491 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00003491 | 1 / 1 |
O00167 | Eyes absent homolog 2 | Enzyme | C00003491 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00003491 | 0 / 0 |
O95267 | RAS guanyl-releasing protein 1 | Unclassified protein | C00003491 | 1 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003491 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00003491 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003491 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003491 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003491 | 1 / 4 |
Q05513 | Protein kinase C zeta type | Iota | C00003491 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003491 | 7 / 37 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00003491 | 0 / 0 |
P41743 | Protein kinase C iota type | Iota | C00003491 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003491 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5244 | ABCB4, ABC21, GBD1, ICP3, MDR2, MDR2/3, MDR3, PFIC-3, PGY3 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 (EC:3.6.3.44) |
C00003491
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00003491
|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00003491
|
1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) |
C00003491
|
60 | ACTB, BRWS1, PS1TP5BP1 | actin, beta |
C00003491
|
8038 | ADAM12, MCMP, MCMPMltna, MLTN, MLTNA | ADAM metallopeptidase domain 12 |
C00003491
|
101 | ADAM8, CD156, MS2 | ADAM metallopeptidase domain 8 (EC:3.4.24.-) |
C00003491
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00003491
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00003491
|
37815 |
C00003491
|
||
11199 | ANXA10, ANX14 | annexin A10 |
C00003491
|
306 | ANXA3, ANX3 | annexin A3 (EC:3.1.4.43) |
C00003491
|
317 | APAF1, APAF-1, CED4 | apoptotic peptidase activating factor 1 |
C00003491
|
27301 | APEX2, APE2, APEXL2, XTH2 | APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (EC:4.2.99.18) |
C00003491
|
334 | APLP2, APLP-2, APPH, APPL2, CDEBP | amyloid beta (A4) precursor-like protein 2 |
C00003491
|
374 | AREG, AR, CRDGF, SDGF | amphiregulin |
C00003491
|
375 | ARF1 | ADP-ribosylation factor 1 |
C00003491
|
382 | ARF6 | ADP-ribosylation factor 6 |
C00003491
|
23229 | ARHGEF9, COLLYBISTIN, EIEE8, HPEM-2, PEM-2, PEM2 | Cdc42 guanine nucleotide exchange factor (GEF) 9 |
C00003491
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00003491
|
10550 | ARL6IP5, DERP11, GTRAP3-18, JWA, PRAF3, addicsin, hp22, jmx | ADP-ribosylation-like factor 6 interacting protein 5 |
C00003491
|
10109 | ARPC2, ARC34, PNAS-139, p34-Arc | actin related protein 2/3 complex, subunit 2, 34kDa |
C00003491
|
445 | ASS1, ASS, CTLN1 | argininosuccinate synthase 1 (EC:6.3.4.5) |
C00003491
|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00003491
|
22809 | ATF5, ATFX, HMFN0395 | activating transcription factor 5 |
C00003491
|
538 | ATP7A, DSMAX, MK, MNK, SMAX3 | ATPase, Cu++ transporting, alpha polypeptide (EC:3.6.3.54) |
C00003491
|
540 | ATP7B, PWD, WC1, WD, WND | ATPase, Cu++ transporting, beta polypeptide (EC:3.6.3.54) |
C00003491
|
6790 | AURKA, AIK, ARK1, AURA, AURORA2, BTAK, PPP1R47, STK15, STK6, STK7 | aurora kinase A (EC:2.7.11.1) |
C00003491
|
573 | BAG1, BAG-1, HAP, RAP46 | BCL2-associated athanogene |
C00003491
|
578 | BAK1, BAK, BAK-LIKE, BCL2L7, CDN1 | BCL2-antagonist/killer 1 |
C00003491
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00003491
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003491
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00003491
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00003491
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00003491
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003491
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00003491
|
650 | BMP2, BDA2, BMP2A | bone morphogenetic protein 2 |
C00003491
|
682 | BSG, 5F7, CD147, EMMPRIN, M6, OK, TCSF | basigin |
C00003491
|
7832 | BTG2, PC3, TIS21 | BTG family, member 2 |
C00003491
|
701 | BUB1B, BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1 | BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) |
C00003491
|
23632 | CA14, CAXiV | carbonic anhydrase XIV (EC:4.2.1.1) |
C00003491
|
811 | CALR, CRT, RO, SSA, cC1qR | calreticulin |
C00003491
|
8536 | CAMK1, CAMKI | calcium/calmodulin-dependent protein kinase I (EC:2.7.11.17) |
C00003491
|
11131 | CAPN11, calpain11 | calpain 11 |
C00003491
|
10753 | CAPN9, GC36, nCL-4 | calpain 9 (EC:3.4.22.-) |
C00003491
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00003491
|
100506742 | CASP12, CASP-12, CASP12P1 | caspase 12 (gene/pseudogene) |
C00003491
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003491
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00003491
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00003491
|
847 | CAT | catalase (EC:1.11.1.6) |
C00003491
|
6346 | CCL1, I-309, P500, SCYA1, SISe, TCA3 | chemokine (C-C motif) ligand 1 |
C00003491
|
6356 | CCL11, SCYA11 | chemokine (C-C motif) ligand 11 |
C00003491
|
6362 | CCL18, AMAC-1, AMAC1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) |
C00003491
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00003491
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00003491
|
6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00003491
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00003491
|
9560 | CCL4L1, AT744.2, CCL4L, LAG-1, LAG1, SCYA4L | chemokine (C-C motif) ligand 4-like 1 |
C00003491
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00003491
|
890 | CCNA2, CCN1, CCNA | cyclin A2 |
C00003491
|
9133 | CCNB2, HsT17299 | cyclin B2 |
C00003491
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00003491
|
896 | CCND3 | cyclin D3 |
C00003491
|
898 | CCNE1, CCNE | cyclin E1 |
C00003491
|
900 | CCNG1, CCNG | cyclin G1 |
C00003491
|
22948 | CCT5, CCT-epsilon, CCTE, TCP-1-epsilon | chaperonin containing TCP1, subunit 5 (epsilon) |
C00003491
|
100136148 |
C00003491
|
||
929 | CD14 | CD14 molecule |
C00003491
|
4345 | CD200, MOX1, MOX2, MRC, OX-2 | CD200 molecule |
C00003491
|
940 | CD28, Tp44 | CD28 molecule |
C00003491
|
947 | CD34 | CD34 molecule |
C00003491
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00003491
|
920 | CD4, CD4mut | CD4 molecule |
C00003491
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00003491
|
959 | CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | CD40 ligand |
C00003491
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00003491
|
965 | CD58, LFA-3, LFA3, ag3 | CD58 molecule |
C00003491
|
969 | CD69, AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3 | CD69 molecule |
C00003491
|
928 | CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29 | CD9 molecule |
C00003491
|
991 | CDC20, CDC20A, bA276H19.3, p55CDC | cell division cycle 20 |
C00003491
|
994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00003491
|
995 | CDC25C, CDC25, PPP1R60 | cell division cycle 25C (EC:3.1.3.48) |
C00003491
|
1015 | CDH17, CDH16, HPT-1, HPT1 | cadherin 17, LI cadherin (liver-intestine) |
C00003491
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00003491
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00003491
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00003491
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00003491
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00003491
|
1029 | CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16 | cyclin-dependent kinase inhibitor 2A |
C00003491
|
1030 | CDKN2B, CDK4I, INK4B, MTS2, P15, TP15, p15INK4b | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
C00003491
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00003491
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00003491
|
1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 |
C00003491
|
1364 | CLDN4, CPE-R, CPER, CPETR, CPETR1, WBSCR8, hCPE-R | claudin 4 |
C00003491
|
1201 | CLN3, BTS, JNCL | ceroid-lipofuscinosis, neuronal 3 |
C00003491
|
8418 | CMAHP, CMAH, CSAH | cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene |
C00003491
|
1240 | CMKLR1, CHEMERINR, ChemR23, DEZ, RVER1 | chemokine-like receptor 1 |
C00003491
|
1264 | CNN1, SMCC, Sm-Calp | calponin 1, basic, smooth muscle |
C00003491
|
27255 | CNTN6, NB3 | contactin 6 |
C00003491
|
1278 | COL1A2, OI4 | collagen, type I, alpha 2 |
C00003491
|
1291 | COL6A1, OPLL | collagen, type VI, alpha 1 |
C00003491
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00003491
|
4513 | COX2, COII, MTCO2, MT-CO2 | cytochrome c oxidase subunit II |
C00003491
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00003491
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00003491
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00003491
|
56253 | CRTAM, CD355 | cytotoxic and regulatory T cell molecule |
C00003491
|
1407 | CRY1, PHLL1 | cryptochrome 1 (photolyase-like) |
C00003491
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00003491
|
1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00003491
|
1487 | CTBP1, BARS | C-terminal binding protein 1 |
C00003491
|
8065 | CUL5, VACM-1, VACM1 | cullin 5 |
C00003491
|
6376 | CX3CL1, ABCD-3, C3Xkine, CXC3, CXC3C, NTN, NTT, SCYD1, fractalkine, neurotactin | chemokine (C-X3-C motif) ligand 1 |
C00003491
|
6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 |
C00003491
|
6374 | CXCL5, ENA-78, SCYB5 | chemokine (C-X-C motif) ligand 5 |
C00003491
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00003491
|
3577 | CXCR1, C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1, CMKAR1, IL8R1, IL8RA, IL8RBA | chemokine (C-X-C motif) receptor 1 |
C00003491
|
3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 |
C00003491
|
1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00003491
|
1536 | CYBB, AMCBX2, CGD, GP91-1, GP91-PHOX, GP91PHOX, NOX2, p91-PHOX | cytochrome b-245, beta polypeptide |
C00003491
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00003491
|
1585 | CYP11B2, ALDOS, CPN2, CYP11B, CYP11BL, CYPXIB2, P-450C18, P450C18, P450aldo | cytochrome P450, family 11, subfamily B, polypeptide 2 (EC:1.14.15.4 1.14.15.5) |
C00003491
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00003491
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00003491
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00003491
|
1581 | CYP7A1, CP7A, CYP7, CYPVII | cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) |
C00003491
|
1612 | DAPK1, DAPK | death-associated protein kinase 1 (EC:2.7.11.1) |
C00003491
|
1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00003491
|
1735 | DIO3, 5DIII, D3, DIOIII, TXDI3 | deiodinase, iodothyronine, type III (EC:1.97.1.11) |
C00003491
|
8788 | DLK1, DLK, DLK-1, Delta1, FA1, PREF1, Pref-1, ZOG, pG2 | delta-like 1 homolog (Drosophila) |
C00003491
|
1806 | DPYD, DHP, DHPDHASE, DPD | dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
C00003491
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00003491
|
51207 | DUSP13, BEDP, DUSP13A, DUSP13B, MDSP, SKRP4, TMDP | dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48) |
C00003491
|
1846 | DUSP4, HVH2, MKP-2, MKP2, TYP | dual specificity phosphatase 4 (EC:3.1.3.16 3.1.3.48) |
C00003491
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00003491
|
8411 | EEA1, MST105, MSTP105, ZFYVE2 | early endosome antigen 1 |
C00003491
|
1945 | EFNA4, EFL4, EPLG4, LERK4 | ephrin-A4 |
C00003491
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00003491
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00003491
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00003491
|
1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00003491
|
1961 | EGR4, NGFI-C, NGFIC, PAT133 | early growth response 4 |
C00003491
|
1977 | EIF4E, AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F | eukaryotic translation initiation factor 4E |
C00003491
|
1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 |
C00003491
|
1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00003491
|
1982 | EIF4G2, AAG1, DAP5, NAT1, P97 | eukaryotic translation initiation factor 4 gamma, 2 |
C00003491
|
1983 | EIF5, EIF-5, EIF-5A | eukaryotic translation initiation factor 5 |
C00003491
|
2002 | ELK1 | ELK1, member of ETS oncogene family |
C00003491
|
2021 | ENDOG | endonuclease G |
C00003491
|
2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00003491
|
2066 | ERBB4, ALS19, HER4, p180erbB4 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 (EC:2.7.10.1) |
C00003491
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00003491
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00003491
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00003491
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00003491
|
2237 | FEN1, FEN-1, MF1, RAD2 | flap structure-specific endonuclease 1 |
C00003491
|
8823 | FGF16, FGF-16, MF4 | fibroblast growth factor 16 |
C00003491
|
2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) |
C00003491
|
2289 | FKBP5, AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10 | FK506 binding protein 5 (EC:5.2.1.8) |
C00003491
|
2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00003491
|
2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00003491
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00003491
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00003491
|
2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B |
C00003491
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00003491
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00003491
|
2309 | FOXO3, AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A | forkhead box O3 |
C00003491
|
2533 | FYB, ADAP, PRO0823, SLAP-130 | FYN binding protein |
C00003491
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00003491
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00003491
|
2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 |
C00003491
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00003491
|
2662 | GDF10, BMP-3b, BMP3B | growth differentiation factor 10 |
C00003491
|
2672 | GFI1, GFI-1, GFI1A, SCN2, ZNF163 | growth factor independent 1 transcription repressor |
C00003491
|
2675 | GFRA2, GDNFRB, NRTNR-ALPHA, NTNRA, RETL2, TRNR2 | GDNF family receptor alpha 2 |
C00003491
|
2694 | GIF, IF, IFMH, INF, TCN3 | gastric intrinsic factor (vitamin B synthesis) |
C00003491
|
2697 | GJA1, AVSD3, CMDR, CX43, DFNB38, GJAL, HLHS1, HSS, ODDD | gap junction protein, alpha 1, 43kDa |
C00003491
|
10578 | GNLY, 519, D2S69E, LAG-2, LAG2, NKG5, TLA519 | granulysin |
C00003491
|
2798 | GNRHR, GNRHR1, GRHR, HH7, LHRHR, LRHR | gonadotropin-releasing hormone receptor |
C00003491
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00003491
|
2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00003491
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00003491
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00003491
|
2968 | GTF2H4, P52, TFB2, TFIIH | general transcription factor IIH, polypeptide 4, 52kDa |
C00003491
|
2993 | GYPA, CD235a, GPA, GPErik, GPSAT, HGpMiV, HGpMiXI, HGpSta(C), MN, MNS, PAS-2 | glycophorin A (MNS blood group) |
C00003491
|
3030 | HADHA, ECHA, GBP, HADH, LCEH, LCHAD, MTPA, TP-ALPHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit (EC:4.2.1.17 1.1.1.211) |
C00003491
|
3035 | HARS, HRS, USH3B | histidyl-tRNA synthetase (EC:6.1.1.21) |
C00003491
|
1839 | HBEGF, DTR, DTS, DTSF, HEGFL | heparin-binding EGF-like growth factor |
C00003491
|
3055 | HCK, JTK9, p59Hck, p61Hck | hemopoietic cell kinase (EC:2.7.10.2) |
C00003491
|
3067 | HDC | histidine decarboxylase (EC:4.1.1.22) |
C00003491
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00003491
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00003491
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00003491
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00003491
|
3157 | HMGCS1, HMGCS | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (EC:2.3.3.10) |
C00003491
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00003491
|
3248 | HPGD, 15-PGDH, PGDH, PGDH1, PHOAR1, SDR36C1 | hydroxyprostaglandin dehydrogenase 15-(NAD) (EC:1.1.1.141) |
C00003491
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00003491
|
3306 | HSPA2, HSP70-2, HSP70-3 | heat shock 70kDa protein 2 |
C00003491
|
3310 | HSPA6 | heat shock 70kDa protein 6 (HSP70B') |
C00003491
|
3312 | HSPA8, HSC54, HSC70, HSC71, HSP71, HSP73, HSPA10, LAP1, NIP71 | heat shock 70kDa protein 8 |
C00003491
|
3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00003491
|
3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00003491
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003491
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00003491
|
3460 | IFNGR2, AF-1, IFGR2, IFNGT1 | interferon gamma receptor 2 (interferon gamma transducer 1) |
C00003491
|
3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00003491
|
3490 | IGFBP7, AGM, FSTL2, IBP-7, IGFBP-7, IGFBP-7v, IGFBPRP1, MAC25, PSF, RAMSVPS, TAF | insulin-like growth factor binding protein 7 |
C00003491
|
3543 | IGLL1, 14.1, AGM2, CD179b, IGL1, IGL5, IGLJ14.1, IGLL, IGO, IGVPB, VPREB2 | immunoglobulin lambda-like polypeptide 1 |
C00003491
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00003491
|
8517 | IKBKG, AMCBX1, FIP-3, FIP3, Fip3p, IKK-gamma, IP, IP1, IP2, IPD2, NEMO, ZC2HC9 | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
C00003491
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00003491
|
3589 | IL11, AGIF, IL-11 | interleukin 11 |
C00003491
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00003491
|
3594 | IL12RB1, CD212, IL-12R-BETA1, IL12RB | interleukin 12 receptor, beta 1 |
C00003491
|
3595 | IL12RB2 | interleukin 12 receptor, beta 2 |
C00003491
|
3596 | IL13, IL-13, P600 | interleukin 13 |
C00003491
|
8809 | IL18R1, CD218a, CDw218a, IL-1Rrp, IL18RA, IL1RRP | interleukin 18 receptor 1 |
C00003491
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00003491
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00003491
|
3554 | IL1R1, CD121A, D2S1473, IL-1R-alpha, IL1R, IL1RA, P80 | interleukin 1 receptor, type I |
C00003491
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00003491
|
3556 | IL1RAP, C3orf13, IL-1RAcP, IL1R3 | interleukin 1 receptor accessory protein |
C00003491
|
26280 | IL1RAPL2, IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1 | interleukin 1 receptor accessory protein-like 2 |
C00003491
|
3557 | IL1RN, DIRA, ICIL-1RA, IL-1RN, IL-1ra, IL-1ra3, IL1F3, IL1RA, IRAP, MVCD4 | interleukin 1 receptor antagonist |
C00003491
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00003491
|
3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha |
C00003491
|
3560 | IL2RB, CD122, IL15RB, P70-75 | interleukin 2 receptor, beta |
C00003491
|
3562 | IL3, IL-3, MCGF, MULTI-CSF | interleukin 3 (colony-stimulating factor, multiple) |
C00003491
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00003491
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00003491
|
3568 | IL5RA, CD125, CDw125, HSIL5R3, IL5R | interleukin 5 receptor, alpha |
C00003491
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00003491
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00003491
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003491
|
3581 | IL9R, CD129, IL-9R | interleukin 9 receptor |
C00003491
|
11213 | IRAK3, ASRT5, IRAKM | interleukin-1 receptor-associated kinase 3 (EC:2.7.11.1) |
C00003491
|
3662 | IRF4, LSIRF, MUM1, NF-EM5 | interferon regulatory factor 4 |
C00003491
|
3673 | ITGA2, BR, CD49B, GPIa, HPA-5, VLA-2, VLAA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
C00003491
|
3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) |
C00003491
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00003491
|
3687 | ITGAX, CD11C, SLEB6 | integrin, alpha X (complement component 3 receptor 4 subunit) |
C00003491
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00003491
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00003491
|
3694 | ITGB6 | integrin, beta 6 |
C00003491
|
3713 | IVL | involucrin |
C00003491
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00003491
|
3726 | JUNB, AP-1 | jun B proto-oncogene |
C00003491
|
3727 | JUND, AP-1 | jun D proto-oncogene |
C00003491
|
3752 | KCND3, KCND3L, KCND3S, KSHIVB, KV4.3, SCA19, SCA22 | potassium voltage-gated channel, Shal-related subfamily, member 3 |
C00003491
|
10112 | KIF20A, MKLP2, RAB6KIFL | kinesin family member 20A |
C00003491
|
9585 | KIF20B, CT90, KRMP1, MPHOSPH1, MPP-1, MPP1 | kinesin family member 20B |
C00003491
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00003491
|
11004 | KIF2C, KNSL6, MCAK | kinesin family member 2C |
C00003491
|
11278 | KLF12, AP-2rep, AP2REP | Kruppel-like factor 12 |
C00003491
|
9314 | KLF4, EZF, GKLF | Kruppel-like factor 4 (gut) |
C00003491
|
1316 | KLF6, BCD1, CBA1, COPEB, CPBP, GBF, PAC1, ST12, ZF9 | Kruppel-like factor 6 |
C00003491
|
3845 | KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2 | Kirsten rat sarcoma viral oncogene homolog |
C00003491
|
3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00003491
|
3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) |
C00003491
|
3976 | LIF, CDF, DIA, HILDA, MLPLI | leukemia inhibitory factor |
C00003491
|
4005 | LMO2, RBTN2, RBTNL1, RHOM2, TTG2 | LIM domain only 2 (rhombotin-like 1) |
C00003491
|
4008 | LMO7, FBX20, FBXO20, LOMP | LIM domain 7 |
C00003491
|
4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00003491
|
4035 | LRP1, A2MR, APOER, APR, CD91, IGFBP3R, LRP, LRP1A, TGFBR5 | low density lipoprotein receptor-related protein 1 |
C00003491
|
8425 | LTBP4, ARCL1C, LTBP-4, LTBP4L, LTBP4S | latent transforming growth factor beta binding protein 4 |
C00003491
|
8379 | MAD1L1, MAD1, PIG9, TP53I9, TXBP181 | MAD1 mitotic arrest deficient-like 1 (yeast) |
C00003491
|
4085 | MAD2L1, HSMAD2, MAD2 | MAD2 mitotic arrest deficient-like 1 (yeast) |
C00003491
|
81631 | MAP1LC3B, ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a | microtubule-associated protein 1 light chain 3 beta |
C00003491
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00003491
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00003491
|
9020 | MAP3K14, FTDCR1B, HS, HSNIK, NIK | mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25) |
C00003491
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003491
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00003491
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003491
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00003491
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00003491
|
9261 | MAPKAPK2, MAPKAP-K2, MK-2, MK2 | mitogen-activated protein kinase-activated protein kinase 2 (EC:2.7.11.1) |
C00003491
|
4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble |
C00003491
|
4223 | MEOX2, GAX, MOX2 | mesenchyme homeobox 2 |
C00003491
|
10461 | MERTK, MER, RP38, c-mer | c-mer proto-oncogene tyrosine kinase (EC:2.7.10.1) |
C00003491
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00003491
|
8569 | MKNK1, MNK1 | MAP kinase interacting serine/threonine kinase 1 (EC:2.7.11.1) |
C00003491
|
4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) |
C00003491
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00003491
|
4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00003491
|
4323 | MMP14, MMP-14, MMP-X1, MT-MMP, MT-MMP_1, MT1-MMP, MT1MMP, MTMMP1, WNCHRS | matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) |
C00003491
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00003491
|
118856 | MMP21, MMP-21 | matrix metallopeptidase 21 |
C00003491
|
4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) |
C00003491
|
4317 | MMP8, CLG1, HNC, MMP-8, PMNL-CL | matrix metallopeptidase 8 (neutrophil collagenase) (EC:3.4.24.34) |
C00003491
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00003491
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00003491
|
10232 | MSLN, MPF, SMRP | mesothelin |
C00003491
|
4481 | MSR1, CD204, SCARA1, SR-A, SRA, phSR1, phSR2 | macrophage scavenger receptor 1 |
C00003491
|
4502 | MT2A, MT2 | metallothionein 2A |
C00003491
|
4582 | MUC1, CA_15-3, CD227, EMA, H23AG, KL-6, MAM6, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | mucin 1, cell surface associated |
C00003491
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00003491
|
7593 | MZF1, MZF-1, MZF1B, ZFP98, ZNF42, ZSCAN6 | myeloid zinc finger 1 |
C00003491
|
4675 | NAP1L3, MB20, NPL3 | nucleosome assembly protein 1-like 3 |
C00003491
|
24142 | NAT6, FUS-2, FUS2 | N-acetyltransferase 6 (GCN5-related) (EC:2.3.1.-) |
C00003491
|
64151 | NCAPG, CAPG, CHCG, NY-MEL-3 | non-SMC condensin I complex, subunit G |
C00003491
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00003491
|
4688 | NCF2, NCF-2, NOXA2, P67-PHOX, P67PHOX | neutrophil cytosolic factor 2 |
C00003491
|
4751 | NEK2, HsPK21, NEK2A, NLK1 | NIMA-related kinase 2 (EC:2.7.11.1) |
C00003491
|
4745 | NELL1, IDH3GL, NRP1 | NEL-like 1 (chicken) |
C00003491
|
4772 | NFATC1, NF-ATC, NFAT2, NFATc | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
C00003491
|
4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
C00003491
|
4775 | NFATC3, NFAT4, NFATX | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
C00003491
|
4776 | NFATC4, NF-ATc4, NFAT3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
C00003491
|
4781 | NFIB, CTF, HMGIC/NFIB, NF-I/B, NF1-B, NFI-B, NFI-RED, NFIB2, NFIB3 | nuclear factor I/B |
C00003491
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00003491
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003491
|
4795 | NFKBIL1, IKBL, LST1, NFKBIL | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 |
C00003491
|
4818 | NKG7, GIG1, GMP-17, p15-TIA-1 | natural killer cell group 7 sequence |
C00003491
|
9111 | NMI | N-myc (and STAT) interactor |
C00003491
|
9221 | NOLC1, NOPP130, NOPP140, NS5ATP13, P130 | nucleolar and coiled-body phosphoprotein 1 |
C00003491
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00003491
|
404036 |
C00003491
|
||
4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00003491
|
124056 | NOXO1, P41NOX, P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28 | NADPH oxidase organizer 1 |
C00003491
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00003491
|
4835 | NQO2, DHQV, DIA6, NMOR2, QR2 | NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) |
C00003491
|
2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00003491
|
3164 | NR4A1, GFRP1, HMR, N10, NAK-1, NGFIB, NP10, NUR77, TR3 | nuclear receptor subfamily 4, group A, member 1 |
C00003491
|
4929 | NR4A2, HZF-3, NOT, NURR1, RNR1, TINUR | nuclear receptor subfamily 4, group A, member 2 |
C00003491
|
8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00003491
|
2494 | NR5A2, B1F, B1F2, CPF, FTF, FTZ-F1, FTZ-F1beta, LRH-1, LRH1, hB1F-2 | nuclear receptor subfamily 5, group A, member 2 |
C00003491
|
51203 | NUSAP1, ANKT, BM037, LNP, NUSAP, PRO0310p1, Q0310, SAPL | nucleolar and spindle associated protein 1 |
C00003491
|
4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00003491
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00003491
|
5063 | PAK3, CDKN1A, MRX30, MRX47, OPHN3, PAK3beta, bPAK, hPAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 (EC:2.7.11.1) |
C00003491
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00003491
|
10038 | PARP2, ADPRT2, ADPRTL2, ADPRTL3, ARTD2, PARP-2, pADPRT-2 | poly (ADP-ribose) polymerase 2 (EC:2.4.2.30) |
C00003491
|
55872 | PBK, CT84, Nori-3, SPK, TOPK | PDZ binding kinase (EC:2.7.12.2) |
C00003491
|
56146 | PCDHA2, PCDH-ALPHA2 | protocadherin alpha 2 |
C00003491
|
5118 | PCOLCE, PCPE, PCPE-1, PCPE1 | procollagen C-endopeptidase enhancer |
C00003491
|
27250 | PDCD4, H731 | programmed cell death 4 (neoplastic transformation inhibitor) |
C00003491
|
5154 | PDGFA, PDGF-A, PDGF1 | platelet-derived growth factor alpha polypeptide |
C00003491
|
5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00003491
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00003491
|
5300 | PIN1, DOD, UBL5 | peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (EC:5.2.1.8) |
C00003491
|
5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00003491
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00003491
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00003491
|
5330 | PLCB2, PLC-beta-2 | phospholipase C, beta 2 (EC:3.1.4.11) |
C00003491
|
5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00003491
|
5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00003491
|
8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) |
C00003491
|
5427 | POLE2, DPE2 | polymerase (DNA directed), epsilon 2, accessory subunit (EC:2.7.7.7) |
C00003491
|
5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 |
C00003491
|
5452 | POU2F2, OCT2, OTF2, Oct-2 | POU class 2 homeobox 2 |
C00003491
|
5459 | POU4F3, BRN3C, DFNA15 | POU class 4 homeobox 3 |
C00003491
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00003491
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00003491
|
5473 | PPBP, B-TG1, Beta-TG, CTAP-III, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, PBP, SCYB7, TC1, TC2, TGB, TGB1, THBGB, THBGB1 | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
C00003491
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00003491
|
5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00003491
|
5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00003491
|
5581 | PRKCE, PKCE, nPKC-epsilon | protein kinase C, epsilon (EC:2.7.11.13) |
C00003491
|
5582 | PRKCG, PKC-gamma, PKCC, PKCG, SCA14 | protein kinase C, gamma (EC:2.7.11.13) |
C00003491
|
5583 | PRKCH, PKC-L, PKCL, PRKCL, nPKC-eta | protein kinase C, eta (EC:2.7.11.13) |
C00003491
|
5584 | PRKCI, DXS1179E, PKCI, nPKC-iota | protein kinase C, iota (EC:2.7.11.13) |
C00003491
|
5588 | PRKCQ, PRKCT, nPKC-theta | protein kinase C, theta (EC:2.7.11.13) |
C00003491
|
5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00003491
|
5587 | PRKD1, PKC-MU, PKCM, PKD, PRKCM | protein kinase D1 (EC:2.7.11.13) |
C00003491
|
9536 | PTGES, MGST-IV, MGST1-L1, MGST1L1, MPGES, PGES, PIG12, PP102, PP1294, TP53I12, mPGES-1 | prostaglandin E synthase (EC:5.3.99.3) |
C00003491
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00003491
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00003491
|
5799 | PTPRN2, IA-2beta, IAR, ICAAR, PTPRP, R-PTP-N2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 (EC:3.1.3.48) |
C00003491
|
9232 | PTTG1, EAP1, HPTTG, PTTG, TUTR1 | pituitary tumor-transforming 1 |
C00003491
|
5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00003491
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00003491
|
10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 |
C00003491
|
5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00003491
|
8438 | RAD54L, HR54, RAD54A, hHR54, hRAD54 | RAD54-like (S. cerevisiae) |
C00003491
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00003491
|
5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 |
C00003491
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00003491
|
5932 | RBBP8, COM1, CTIP, JWDS, RIM, SAE2, SCKL2 | retinoblastoma binding protein 8 |
C00003491
|
9978 | RBX1, BA554C12.1, RNF75, ROC1 | ring-box 1, E3 ubiquitin protein ligase |
C00003491
|
5966 | REL, C-Rel | v-rel avian reticuloendotheliosis viral oncogene homolog |
C00003491
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00003491
|
5984 | RFC4, A1, RFC37 | replication factor C (activator 1) 4, 37kDa |
C00003491
|
5985 | RFC5, RFC36 | replication factor C (activator 1) 5, 36.5kDa |
C00003491
|
28984 | RGCC, C13orf15, RGC-32, RGC32, bA157L14.2 | regulator of cell cycle |
C00003491
|
8786 | RGS11, RS11 | regulator of G-protein signaling 11 |
C00003491
|
6003 | RGS13 | regulator of G-protein signaling 13 |
C00003491
|
391 | RHOG, ARHG | ras homolog family member G |
C00003491
|
8635 | RNASET2, RNASE6PL, bA514O12.3 | ribonuclease T2 (EC:3.1.27.1) |
C00003491
|
6194 | RPS6, S6 | ribosomal protein S6 |
C00003491
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00003491
|
6279 | S100A8, 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, MA387, MIF, MRP8, NIF, P8 | S100 calcium binding protein A8 |
C00003491
|
6280 | S100A9, 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG, MAC387, MIF, MRP14, NIF, P14 | S100 calcium binding protein A9 |
C00003491
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00003491
|
9092 | SART1, Ara1, HOMS1, SART1259, SNRNP110, Snu66 | squamous cell carcinoma antigen recognized by T cells |
C00003491
|
6382 | SDC1, CD138, SDC, SYND1, syndecan | syndecan 1 |
C00003491
|
6385 | SDC4, SYND4 | syndecan 4 |
C00003491
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00003491
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00003491
|
5272 | SERPINB9, CAP-3, CAP3, PI-9, PI9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
C00003491
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00003491
|
10262 | SF3B4, AFD1, Hsh49, SAP49, SF3b49 | splicing factor 3b, subunit 4, 49kDa |
C00003491
|
22941 | SHANK2, AUTS17, CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3 | SH3 and multiple ankyrin repeat domains 2 |
C00003491
|
6464 | SHC1, SHC, SHCA | SHC (Src homology 2 domain containing) transforming protein 1 |
C00003491
|
7979 | SHFM1, DSS1, ECD, SEM1, SHFD1, SHSF1, Shfdg1 | split hand/foot malformation (ectrodactyly) type 1 |
C00003491
|
946 | SIGLEC6, CD327, CD33L, CD33L1, CD33L2, CDW327, OBBP1 | sialic acid binding Ig-like lectin 6 |
C00003491
|
6503 | SLA, SLA1, SLAP | Src-like-adaptor |
C00003491
|
6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
C00003491
|
8884 | SLC5A6, SMVT | solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
C00003491
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00003491
|
23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00003491
|
10051 | SMC4, CAP-C, CAPC, SMC-4, SMC4L1, hCAP-C | structural maintenance of chromosomes 4 |
C00003491
|
8835 | SOCS2, CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2 | suppressor of cytokine signaling 2 |
C00003491
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00003491
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00003491
|
6667 | SP1 | Sp1 transcription factor |
C00003491
|
10615 | SPAG5, DEEPEST, MAP126, hMAP126 | sperm associated antigen 5 |
C00003491
|
6688 | SPI1, OF, PU.1, SFPI1, SPI-1, SPI-A | spleen focus forming virus (SFFV) proviral integration oncogene |
C00003491
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00003491
|
6698 | SPRR1A, SPRK | small proline-rich protein 1A |
C00003491
|
6699 | SPRR1B, CORNIFIN, GADD33, SPRR1 | small proline-rich protein 1B |
C00003491
|
6700 | SPRR2A | small proline-rich protein 2A |
C00003491
|
6734 | SRPR, DP, Sralpha | signal recognition particle receptor (docking protein) |
C00003491
|
10492 | SYNCRIP, GRY-RBP, GRYRBP, HNRNPQ, HNRPQ1, NSAP1, PP68, hnRNP-Q | synaptotagmin binding, cytoplasmic RNA interacting protein |
C00003491
|
8148 | TAF15, Npl3, RBP56, TAF2N, TAFII68 | TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa |
C00003491
|
6876 | TAGLN, SM22, SMCC, TAGLN1, WS3-10 | transgelin |
C00003491
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00003491
|
7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor |
C00003491
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00003491
|
7042 | TGFB2, LDS4, TGF-beta2 | transforming growth factor, beta 2 |
C00003491
|
7051 | TGM1, ARCI1, ICR2, KTG, LI, LI1, TGASE, TGK | transglutaminase 1 (EC:2.3.2.13) |
C00003491
|
7066 | THPO, MGDF, MKCSF, ML, MPLLG, THCYT1, TPO | thrombopoietin |
C00003491
|
10440 | TIMM17A, TIM17, TIM17A | translocase of inner mitochondrial membrane 17 homolog A (yeast) |
C00003491
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00003491
|
7077 | TIMP2, CSC-21K, DDC8 | TIMP metallopeptidase inhibitor 2 |
C00003491
|
10333 | TLR6, CD286 | toll-like receptor 6 |
C00003491
|
3371 | TNC, 150-225, DFNA56, GMEM, GP, HXB, JI, TN, TN-C | tenascin C |
C00003491
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00003491
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00003491
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00003491
|
7133 | TNFRSF1B, CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B, TNFR2, TNFR80, p75, p75TNFR | tumor necrosis factor receptor superfamily, member 1B |
C00003491
|
3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 |
C00003491
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00003491
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00003491
|
7163 | TPD52, D52, N8L, PC-1, PrLZ, hD52 | tumor protein D52 |
C00003491
|
22974 | TPX2, C20orf1, C20orf2, DIL-2, DIL2, FLS353, GD:C20orf1, HCA519, HCTP4, REPP86, p100 | TPX2, microtubule-associated |
C00003491
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00003491
|
6967 |
C00003491
|
||
29953 | TRHDE, PAP-II, PGPEP2, TRH-DE | thyrotropin-releasing hormone degrading enzyme (EC:3.4.19.6) |
C00003491
|
28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00003491
|
7442 | TRPV1, VR1 | transient receptor potential cation channel, subfamily V, member 1 |
C00003491
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00003491
|
1890 | TYMP, ECGF, ECGF1, MEDPS1, MNGIE, MTDPS1, PDECGF, TP, hPD-ECGF | thymidine phosphorylase (EC:2.4.2.4) |
C00003491
|
7298 | TYMS, HST422, TMS, TS | thymidylate synthetase (EC:2.1.1.45) |
C00003491
|
7305 | TYROBP, DAP12, KARAP, PLOSL | TYRO protein tyrosine kinase binding protein |
C00003491
|
29128 | UHRF1, ICBP90, Np95, RNF106, hNP95, hUHRF1 | ubiquitin-like with PHD and ring finger domains 1 (EC:6.3.2.19) |
C00003491
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00003491
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00003491
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00003491
|
7431 | VIM, CTRCT30 | vimentin |
C00003491
|
7434 | VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R | vasoactive intestinal peptide receptor 2 |
C00003491
|
6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 |
C00003491
|
9839 | ZEB2, HSPC082, SIP-1, SIP1, SMADIP1, ZFHX1B | zinc finger E-box binding homeobox 2 |
C00003491
|
9310 | ZNF235, ANF270, HZF6, ZFP93, ZNF270 | zinc finger protein 235 |
C00003491
|
113835 | ZNF257, BMZF-4, BMZF4 | zinc finger protein 257 |
C00003491
|
11130 | ZWINT, HZwint-1, KNTC2AP, ZWINT1 | ZW10 interacting kinetochore protein |
C00003491
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#210900 | Bloom syndrome; blm |
P54132
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P24723
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#152700 | Systemic lupus erythematosus; sle |
O95267
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D001932 | Brain Neoplasms |
C00003491
|
D002277 | Carcinoma |
C00003491
|
D006528 | Carcinoma, Hepatocellular |
C00003491
|
D002294 | Carcinoma, Squamous Cell |
C00003491
|
D002471 | Cell Transformation, Neoplastic |
C00003491
|
D017453 | Dermatitis, Irritant |
C00003491
|
D004487 | Edema |
C00003491
|
D006930 | Hyperalgesia |
C00003491
|
D006965 | Hyperplasia |
C00003491
|
D007249 | Inflammation |
C00003491
|
D017254 | Leukemic Infiltration |
C00003491
|
D008113 | Liver Neoplasms |
C00003491
|
D008175 | Lung Neoplasms |
C00003491
|
D008325 | Mammary Neoplasms, Experimental |
C00003491
|
D009336 | Necrosis |
C00003491
|
D009361 | Neoplasm Invasiveness |
C00003491
|
D009362 | Neoplasm Metastasis |
C00003491
|
D009374 | Neoplasms, Experimental |
C00003491
|
D010190 | Pancreatic Neoplasms |
C00003491
|
D010212 | Papilloma |
C00003491
|
D012868 | Skin Abnormalities |
C00003491
|
D012878 | Skin Neoplasms |
C00003491
|
D020301 | Vasospasm, Intracranial |
C00003491
|